Cindy L. Schwartz
-
- Childhood Cancer Survivors' Quality of Life 51
- Oncology top 1%
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 68
-
- Acute Lymphoblastic Leukemia research 47
- Speech and Hearing top 0.5%
-
- Sarcoma Diagnosis and Treatment 27
- Lung Cancer Treatments and Mutations 14
-
- Chemotherapy-induced cardiotoxicity and mitigation 14
-
- CNS Lymphoma Diagnosis and Treatment 11
- Neuroblastoma Research and Treatments 11
- Co-authors
- Debra L. FriedmanWendy L. HobbieNeyssa MarinaWendy M. LeisenringMelissa M. HudsonNina S. Kadan‐LottickAnn MertensAnna T. Meadows
- Journals
- New England Journal of Medicine (2 papers)Journal of Clinical Oncology (30 papers)Blood (20 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Cindy L. Schwartz
142 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Pediatrics, Perinatology and Child Health 3.1k
- Oncology 2.3k
- Pathology and Forensic Medicine 1.4k
- Public Health, Environmental and Occupational Health 2.1k
- Speech and Hearing 478
Countries citing papers authored by Cindy L. Schwartz
This map shows the geographic impact of Cindy L. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy L. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy L. Schwartz more than expected).
Fields of papers citing papers by Cindy L. Schwartz
This network shows the impact of papers produced by Cindy L. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy L. Schwartz. The network helps show where Cindy L. Schwartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cindy L. Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 40 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 38 | |
| 7 | 2021 | 2 | |
| 8 | 2017 | 12 | |
| 9 | 2017 | 2 | |
| 10 | 2016 | 14 | |
| 11 | 2015 | 7 | |
| 12 | 2012 | 44 | |
| 13 | 2011 | 1 | |
| 14 | 2010 | 16 | |
| 15 | 2009 | 27 | |
| 16 | Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Groupbreakdown → | 2008 | 520 |
| 17 | Chronic Health Conditions in Adult Survivors of Childhood Cancerbreakdown → | 2006 | 2551 |
| 18 | 2005 | 26 | |
| 19 | 2005 | 25 | |
| 20 | 2002 | 118 |
About Cindy L. Schwartz
Cindy L. Schwartz is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 145 papers that have together received 8.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (68 papers), Childhood Cancer Survivors' Quality of Life (51 papers), Acute Lymphoblastic Leukemia research (47 papers), Sarcoma Diagnosis and Treatment (27 papers), Lung Cancer Treatments and Mutations (14 papers), Chemotherapy-induced cardiotoxicity and mitigation (14 papers), CNS Lymphoma Diagnosis and Treatment (11 papers) and Neuroblastoma Research and Treatments (11 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (3.1k citations), Oncology (2.3k citations) and Pathology and Forensic Medicine (1.4k citations). Cindy L. Schwartz has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Debra L. Friedman, Wendy L. Hobbie, Neyssa Marina, Wendy M. Leisenring, Melissa M. Hudson, Nina S. Kadan‐Lottick, Ann Mertens, Anna T. Meadows, Kevin C. Oeffinger and Leslie L. Robison. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.